Company: Sonnet BioTherapeutics Inc.
Job title: Chief Scientific Officer & Co-Founder
PANEL DISCUSSION: Where Are We Now & Where Are We Going? 9:30 am
This panel will set out to address Where have the current cytokine engineering strategies taken us and what can we learn from this? Assessing the latest clinical work with lesser known and novel cytokines Assessing the fields biggest roadblocks for moving current promising pre-clinical candidates into the clinic Assessing the role of combination therapies with…Read more
day: Day One